Du Pasquier RA - Search Results

1

Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.

Du Pasquier RA, Pinschewer DD, Merkler D. Du Pasquier RA, et al. CNS Drugs. 2014 Jun;28(6):535-58. doi: 10.1007/s40263-014-0160-8. CNS Drugs. 2014. PMID: 24723124 Free PMC article. Review.

2

[Immunomodulatory/suppressive treatments in neurology].

Schluep M, Chofflon M, Kuntzer T, Du Pasquier R. Schluep M, et al. Rev Med Suisse. 2005 May 4;1(18):1229-32. Rev Med Suisse. 2005. PMID: 15977712 Review. French.

3

[Immunity and neurodegeneration: new concepts in multiple sclerosis].

Lalive PH, Schluep M, Chofflon M, Du Pasquier R. Lalive PH, et al. Rev Med Suisse. 2006 May 3;2(64):1166-8, 1170. Rev Med Suisse. 2006. PMID: 16734188 Review. French.

4

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.

Lysandropoulos AP, Jaquiéry E, Jilek S, Pantaleo G, Schluep M, Du Pasquier RA. Lysandropoulos AP, et al. Among authors: du pasquier ra. J Neuroimmunol. 2011 Apr;233(1-2):240-4. doi: 10.1016/j.jneuroim.2010.11.008. Epub 2010 Dec 24. J Neuroimmunol. 2011. PMID: 21186064

5

[Multiple sclerosis: beyong first line therapies].

Schluep M, Du Pasquier R. Schluep M, et al. Rev Med Suisse. 2012 May 2;8(339):946-9. Rev Med Suisse. 2012. PMID: 22675826 Review. French.

6

[New treatment options in multiple sclerosis and their complications].

Schluep M, Lalive PH, Du Pasquier RA. Schluep M, et al. Among authors: du pasquier ra. Rev Med Suisse. 2013 May 1;9(384):940-3. Rev Med Suisse. 2013. PMID: 23717904 French.

7

Assessing risks of multiple sclerosis therapies.

Parfenov V, Schluep M, Du Pasquier R. Parfenov V, et al. J Neurol Sci. 2013 Sep 15;332(1-2):59-65. doi: 10.1016/j.jns.2013.06.013. Epub 2013 Jul 5. J Neurol Sci. 2013. PMID: 23835089 Review.

8

Environmental factors in multiple sclerosis.

Pantazou V, Schluep M, Du Pasquier R. Pantazou V, et al. Presse Med. 2015 Apr;44(4 Pt 2):e113-20. doi: 10.1016/j.lpm.2015.01.001. Epub 2015 Mar 2. Presse Med. 2015. PMID: 25744944

9

Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.

Parfenov V, Du Pasquier R, Schluep M. Parfenov V, et al. Neurologist. 2015 Jun;19(6):155-7. doi: 10.1097/NRL.0000000000000030. Neurologist. 2015. PMID: 26075469

10

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier RA. Perriard G, et al. Among authors: du pasquier ra. J Neuroinflammation. 2015 Jun 16;12:119. doi: 10.1186/s12974-015-0335-3. J Neuroinflammation. 2015. PMID: 26077779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters